We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.92 | -0.63% | 145.90 | 147.175 | 145.95 | 146.70 | 6,182,981 | 00:52:45 |
By Peter Loftus
A California judge ordered Johnson & Johnson to pay $344 million in a lawsuit in which state officials accused the company of deceptively marketing surgical mesh devices for use in pelvic procedures in women.
Then-California Attorney General Kamala Harris sued J&J and its Ethicon unit in 2016, saying the company marketed its mesh devices as being safe treatments for conditions including stress urinary incontinence, but concealed or misrepresented serious risks such as chronic pain and sexual dysfunction.
The lawsuit said J&J's behavior violated state laws against unfair competition and false advertising.
San Diego Superior Court Judge Eddie Sturgeon on Thursday ordered the company to pay the penalty, after a trial in 2019.
"J&J knew the dangers but put its profits ahead of the health of millions of women," California's current attorney general, Xavier Becerra, said in a statement. "Today we achieved justice for the women forever scarred by this dishonesty."
J&J said it would appeal the decision, a process that could take one to three years. J&J said its Ethicon business "responsibly communicated the risks and benefits of its transvaginal mesh products to doctors and patients." The company said that during the 2019 trial, the state failed to present evidence proving that any California doctor or patient was actually or likely to be misled by any communication from Ethicon.
J&J has previously settled some other litigation over the safety of its mesh devices, including an October 2019 agreement to pay $116.9 million to 41 states and the District of Columbia. J&J didn't admit liability or misconduct in that settlement.
About 19,800 plaintiffs had lawsuits pending against J&J as of Sept. 29, 2019, alleging pelvic meshes caused injuries.
J&J is facing lawsuits from a total of about 100,000 plaintiffs over the safety and marketing of a range of products including opioids and baby powder.
Write to Peter Loftus at peter.loftus@wsj.com
(END) Dow Jones Newswires
January 30, 2020 20:07 ET (01:07 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions